Start-up Lifespin launches therapeutic drug monitoring of anti-infectives

An important step towards integrating precision medicine and antibiotic resistance control

07-Dec-2023 - Lifespin GmbH, an emerging company in the field of precision health information, introduces its Therapeutic Drug Monitoring (TDM) of anti-infectives. This Laboratory Development Test (LDT) represents a significant advance in the field of personalized medicine by enabling individualized approaches ...

Lifespin partners with the Leipzig Research Center for Civilization Diseases to obtain deep clinical insights for obesity and diabetes

27-Apr-2023 - Lifespin GmbH announced that it has entered into a significant scientific collaborative agreement with Leipzig Research Center for Civilization Diseases (LIFE) and Leipzig Medical Biobank to study whether certain patients who are obese or have diabetes have identifiable variations in their ...

Lifespin secures bridge financing

Artificial intelligence to determine health status and diagnose diseases

18-Jan-2022 - Lifespin GmbH in BioPark Regensburg has successfully concluded bridge financing to a total of € 2.5 million. The diagnostic data company is working successfully on an AI-based health platform that can measure important metabolic parameters in patients and expects to start series A in the funding ...